Kadmon Holdings Inc 's

Name: Kadmon Holdings Inc Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

KDMN Sales vs. its Competitors Q3 2021

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

Kadmon holdings inc , faster than the decline experienced by the competitors recorded a net loss, as well as most of its competitors.

<< KDMN Stock Performance Comparisons

<< See the full list of KDMN competitors

*Market share is calculated based on total revenue.

KDMN's Stock Performance relative to its Competitors

Publicly Traded Peers of Kadmon holdings inc

Sagimet Biosciences inc
Share Performance

+8.20%

30 Days

Sagimet Biosciences inc

Profile

Sagimet Biosciences Inc is a biopharmaceutical company that operates on a research-based business model focused on developing therapeutic solutions for metabolic diseases. They employ a multidisciplinary approach that combines scientific research, preclinical assessments, and clinical trials to advance their drug candidates. Sagimet Biosciences aims to bring effective treatments to patients by leveraging their expertise in metabolic disease biology and collaborating with key stakeholders in the medical community.

More about Sagimet Biosciences inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 589.040 mill.	$ - mill.	$ -47.079 mill.

Vivosim Labs Inc
Share Performance

-87.48%

This Year

Vivosim Labs Inc

Profile

The company supports external clinical development and conducts drug discovery and research and development programs.

More about Vivosim Labs Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 1.233 mill.	$ 0.112 mill.	$ -12.338 mill.

Sources: Kadmon holdings inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Saturday, September 5, 2026 4:00 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Kadmon holdings inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.